Cord Blood. Investieren in die Zukunft von Morgen.
Außerdem gab es Gestern ein "Shoorting Star".
Der kurze sehr schnelle Anstieg ist auch ein Warnzeichen. Danach geht es meist auch
wieder sehr schnell abwärts. Jedenfalls meine Erfahrung.
Cord Blood America Says Nine Month Revenues Up 59 Percent to $4.38 Million
-- Gross Profit Up 91 Percent --
http://www.finanznachrichten.de/...o-n-cord-blood-america-inc-008.htm
Real-Time Best Bid & Ask
0.063 / 0.065 (1 x 1)Why is size 1?
Previous Close 0.048 Open 0.052
Daily Range 0.067 - 0.05 52wk Range 0.55 - 0.015
Volume 2,719,642 Dividend N/A
Average Vol (3m) 1,340,042 Yield N/A
Revenues for the three months ended September 30, 2011 totaled $17,200,000, up 118 percent compared to revenues of $7,901,000 in the same period in 2010.
"We are delighted by this significant increase in revenues," said Clark Marcus, CompCare's Chairman and Chief Executive Officer. "A year ago, the Company's revenues for the nine-month period ended September 30, 2010 were up 66% from the same nine-month period in 2009. The entire two-year period of 2009 to 2011 represented a material transition and growth time for the Company during which the Company not only maintained full staff but added significant executive personnel in order to position the Company for profitability. By successfully increasing the Company's business and adding top-line revenue, we believe the Company is on the track to achieve sustainable profitability in 2012, and we look forward to continuing to announce this progress to our investors." The entire 10-Q filing is available at www.sec.gov.
CompCare's revenues are obtained through managed care activities, the majority of which are performed under the terms of at-risk agreements with health maintenance organizations and other health plans or payers to provide contracted behavioral healthcare services to subscribing participants. Revenue under a substantial portion of these agreements is earned monthly based on the number of qualified participants regardless of services actually provided. This is generally referred to as at-risk arrangements.
Under certain behavioral health contracts CompCare also manages the psychotropic drug benefit for the health plan's subscribing participants and is responsible for the cost of drugs dispensed. Pharmacy drug management revenue is recognized monthly at a contracted rate per eligible member. In accordance with the contracts, the health plan's pharmacy benefit manager performs drug price negotiation and claims adjudication.
Bin nicht mehr auf dem Laufenden bei CBAI, also wer weiß was diese Nachricht verbirgt.
Cord Blood America kündigt DTCC Entfernt "Chill" im Dezember 2010 Imposed
http://www.finanznachrichten.de/...tock-price-2012-strategies-008.htm